Skip to main content

Peer Review reports

From: Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer

Original Submission
9 Jan 2024 Submitted Original manuscript
23 Jan 2024 Author responded Author comments - Yulan Sun
Resubmission - Version 2
23 Jan 2024 Submitted Manuscript version 2
28 Feb 2024 Reviewed Reviewer Report
28 Mar 2024 Reviewed Reviewer Report
19 Apr 2024 Author responded Author comments - Yulan Sun
Resubmission - Version 3
19 Apr 2024 Submitted Manuscript version 3
25 Apr 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
26 Apr 2024 Editorially accepted
7 May 2024 Article published 10.1186/s12885-024-12315-5

You can find further information about peer review here.

Back to article page